Archives: Agenda

• Overview of global clinical trials for 2024
• Assessing key sponsors, top interventions and looking at the trial landscape for 2024
• Looking at key obstacles for terminated trials and evaluation of completed trials which have achieved endpoint status.

• Where are the main hurdles patients face and how can these be removed?
• Addressing low levels of health literacy in the patient population: how to improve communication
• Engaging patients and advocacy groups early on in the clinical trial design process
• Barriers to clinical trial participation from a patient perspective
• Patient reimbursement: how to relieve financial pressures on patients participating in trials

• Planning for a successful sponsor/CRO relationship
• Overview of common challenges and pitfalls when working with your CRO
• Sharing best practices to gather market knowledge
• Transition to strategic partnership

We will explore how AI  and Real-World Data (RWD) are reshaping clinical trials. We will delve into how our Data Space Platform addresses industry challenges by ensuring efficient, secure, and structured access to clinical data within the framework of the European Health Data Space (EHDS). Our technology, powered by Artificial Intelligence and Natural Language Processing (NLP), extracts, structures, and harmonizes unstructured clinical data, enabling seamless interoperability and maximizing its value for research. As data mediators, we bridge the gap between data providers and the industry, accelerating patient identification, optimizing recruitment, and enhancing data quality in clinical trials.
Through concrete use cases, we will demonstrate how our platform has driven the success of clinical trials by providing fast and reliable access to clinical data while aligning with European regulations and standards.